News & events

ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY

Read more

ABL PARTNERS WITH KALIVIR IMMUNOTHERAPEUTICS TO ADVANCE DEVELOPMENT OF ONCOLYTIC VIRUSES

Read more

COAVE THERAPEUTICS AND ABL ENTER INTO STRATEGIC COLLABORATION

Read more